Murdo Gordon named EVP and chief commercial officer at B-MS

Murdo Gordon has been appointed executive vice president and chief commercial officer, a newly-created position, at US pharma major Bristol-Myers Squibb (NYSE: BMY), effective June 21, 2016.

Mr Gordon will be responsible for leading the execution of commercial strategy across geographies. In this role, he will lead the firm’s Worldwide Markets in addition to a new Worldwide Commercialization team. He will continue to report to Giovanni Caforio, chief executive, and remain a member of his Leadership Team. Gordon most recently co-led the B-MS commercial organization as head of Worldwide Markets.

“Murdo has demonstrated tremendous success driving commercial excellence at Bristol-Myers Squibb, and built strong relationships with our markets across the world,” said Dr Caforio, adding: “Murdo has made significant contributions to our success in Immuno-Oncology and Eliquis, and I am confident his leadership will help drive continued growth and deliver our medicines to more patients faster.”